Sensitization of chondrosarcoma cells with PARP inhibitor and high-LET radiation - Archive ouverte HAL Accéder directement au contenu
Article Dans Une Revue Journal of Bone Oncology Année : 2019

Sensitization of chondrosarcoma cells with PARP inhibitor and high-LET radiation

Résumé

Chondrosarcoma is a malignant tumor that arises from cartilaginous tissue and is radioresistant and chemoresistant to conventional treatments. The preferred treatment consists of surgical resection, which might cause severe disabilities for the patient; in addition, this procedure might be impossible for inoperable locations, such as the skull base. Carbon ion irradiation (hadron therapy) has been proposed as an alternative treatment, primarily due to its greater biological effectiveness and improved ballistic properties compared with conventional radiotherapy with X-rays. The goal of this study was to characterize the genetic mutations of a grade III chondrosarcoma cell line (CH2879) and examine the cellular responses to conventional radiotherapy (X-rays) and hadron therapy (proton and carbon ions) in the presence of the PARP inhibitor Olaparib. To better understand PARP inhibition, we first analyzed the formation of poly-ADP ribose chains by western blot; we observed an increase in its signal after irradiation, which disappeared on addition of the PARP inhibitor. PARPi enhanced ratio of approximately 1.3, 1.8, and 1.5 following irradiation of cells with X-rays, protons, and C-ions, respectively, as detected by clonogenic assay. The decrease in cell survival was confirmed by proliferation assay. The radiosensitivity of CH2879 cells was associated with mutations in homologous recombination repair genes, such as RAD50, SMARCA2 and NBN. This study demonstrates the capacity of the PARP inhibitor Olaparib to radiosensitize mutated chondrosarcoma cells to conventional photon irradiation, proton and carbon ion irradiation.
Fichier principal
Vignette du fichier
2019 Cesaire et al JBO.pdf (3.75 Mo) Télécharger le fichier
Origine : Fichiers produits par l'(les) auteur(s)

Dates et versions

hal-02332712 , version 1 (26-02-2021)

Identifiants

Citer

Mathieu Césaire, Utpal Ghosh, Jean-Baptiste Austry, Etienne Müller, Francesco Paolo Cammarata, et al.. Sensitization of chondrosarcoma cells with PARP inhibitor and high-LET radiation. Journal of Bone Oncology, 2019, 17, pp.100246. ⟨10.1016/j.jbo.2019.100246⟩. ⟨hal-02332712⟩
114 Consultations
26 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More